Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals

Carli Cahill on LinkedIn: Providence and GRAIL Expand Partnership to Increase Access to Galleri®…

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - ScienceDirect

The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit

A spectroscopic liquid biopsy for the earlier detection of multiple cancer types

Early detection of cancer

The Lancet Oncology Publishes Results from SYMPLIFY, The First Prospective Study of a Multi-Cancer Early Detection Test in a Symptomatic Patient Population - GRAIL

Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma

Understanding Liquid Biopsy for Early Cancer Detection and Screening — BLOODPAC

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer